✦ LIBER ✦

Poster 28: Delphi Process for the Development of Treatment Guidelines for Behavioral Symptoms and Chorea in Huntington's Disease

✍ Scribed by E. van Duijn; M. Groves; D. Craufurd; K. Anderson; M. Guttman; E. Wexler; S. Perlman; J.-M. Burgunder; A. Rosenblatt; D. van Kammen; J. Giuliano; L. Goodman

Book ID: 116800864
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 85 KB
Volume: 7
Category: Article
ISSN: 1933-7213
DOI: 10.1016/j.nurt.2009.10.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster 24: Expert Treatment Preferences

Poster 24: Expert Treatment Preferences for the Motor, Mood, and Behavioral Symptoms of Huntington's Disease

✍ L. Veatch Goodman; J. Cha; P. Como 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 44 KB

Open-label pilot study of levetiracetam

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease

✍ Theresa A. Zesiewicz; Kelly L. Sullivan; Robert A. Hauser; Juan Sanchez-Ramos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective open‐label pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo